Carl Pepine, MD
Cardiovascular Disease · Gainesville, FLNPI 1033124789
Payments from drug & device makers
Across 172 payments — averaging $3074.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$334K
- Biocardia, Inc.$55K
- Janssen Research & Development, LLC$54K
- GE HealthCare$48K
- Johnson & Johnson$15K
- Amgen$8K
- plus $15K from 10 others
Across 1 payment — averaging $3583.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$4K
What the payments were for
- Consulting fees$76,85893%
- Speaking & faculty fees$3,5404%
- Travel & lodging$1,1231%
- Food & beverage$1,1631%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 115 | $333,503 |
| Biocardia, Inc. | 4 | $55,459 |
| Janssen Research & Development, LLC | 8 | $54,114 |
| GE HealthCare | 23 | $47,923 |
| Johnson & Johnson | 10 | $14,675 |
| Amgen | 1 | $7,861 |
| Janssen Scientific Affairs, LLC | 1 | $5,000 |
| Idorsia Pharmaceuticals US Inc | 1 | $3,540 |
| Sanofi US Services Inc. | 2 | $2,792 |
| Janssen Global Services, LLC | 1 | $2,153 |
| Heartflow, Inc. | 1 | $1,500 |
| Medtronic | 1 | $125 |
| Cardiovascular Systems Inc. | 1 | $118 |
| Esperion Therapeutics, Inc. | 1 | $47 |
| Akcea Therapeutics, Inc. | 1 | $36 |
| Novo Nordisk | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tryvio$3,540
- FFRct$1,500
- Resolute$125
- Peripheral Orbital Atherectomy System$118
- Coronary Orbital Atherectomy System$118
How this compares
$528,877 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Gainesville
- Michael KorenGainesville$31M
- Seth BaumBoca Raton$11.1M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
- Duccio BaldariWellington$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.